|
|
||||||||
|
FJ
EXPRESS SUMMARY ARTICLE The Full-length version of this article is also available, published online April 4, 2005 as doi:10.1096/fj.04-2469fje. |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||





* Institut für Physiologie, Universität Regensburg, Regensburg, Germany;
School of Biomedical Sciences, Department of Physiology and Pharmacology, University of Queensland, St. Lucia, Brisbane, Australia; and
Mukoviszidose-Zentrum, Universitäts-Kinderklinik III, Heidelberg, Germany
1Correspondence: E-mail: uqkkunze{at}mailbox.uq.edu.au
SPECIFIC AIMS
PROTEASE activated receptors type 2 (PAR-2) are expressed abundantly in the respiratory tract. However, virtually nothing is known about their role for the fluid transport in native airways. This prompted us to examine the role of PAR-2 for electrolyte transport in the respiratory tract and to unmask the underlying second messenger pathways and contributing ion conductances.
PRINCIPAL FINDINGS
1. PAR-2 are expressed in airway epithelial cells, where they are activated by mast cell tryptase and neutrophil proteinase 3 or trypsin
Although PAR-2 appear to be expressed predominantly on the apical side of the epithelium, only basolateral stimulation results in inhibition of amiloride sensitive Na+ conductance and stimulation of both luminal Cl channels and basolateral K+ channels (Fig. 1
).
|
2. The presents data indicate that these changes occur through activation of phospholipase C and increase of intracellular Ca2+, which activates basolateral SK4 K+ channels and luminal Ca2+-dependent Cl channels
3. The secretory response in tracheas upon stimulation of PAR-2 was comparable for wild-type (WT) mice, CF mice homozygous for the severe CFTR mutation G551D (cftrG551D/G551D), and bitransgenic cftrG551D/G551D K18-GFP-CFTR+/ (G551D/CFTR) animals
4. Evidence is presented that stimulation of PAR-2 in the airways mediates release of prostaglandin E2, which contributes to the secretory response by increasing intracellular cAMP in columnar epithelial cells, thus activating luminal CFTR Clchannels and basolateral KCNQ1 K+ channels
5. Ion transport was activated by trypsin, tryptase, and PAR-2-activating peptide and was independent of simultaneous application of tetrodotoxin, indicating stimulation of electrolyte secretion by direct binding to epithelial PAR-2 receptors
CONCLUSIONS AND SIGNIFICANCE
Taken together, the present data show multiple effects on airway electrolyte transport by stimulation of PAR-2 receptors (Fig. 2
). The results provide further evidence for a role of PAR-2 in inflammatory airway disease. PAR-2 may participate in the hypersecretion and bronchorrhea observed in asthma and other inflammatory diseases such as bronchitis. Stimulation of PAR-2 in columnar epithelial cells induces electrolyte secretion and inhibition of electrogenic Na+ absorption. PAR-2 expressed on basal cells of the airway epithelium may be in charge of PGE2 release, indirectly contributing to electrolyte secretion. Activation of electrolyte secretion and inhibition of absorption may have a protective rather than a proinflammatory function. The bronchodilation and thus protective role of PAR-2 may be accomplished by a switch of epithelial transport from absorption toward secretion, which will increase airway surface liquid. This will improve mucociliary clearance and thus may flush noxious stimuli and bacteria away from the affected area.
|
|
FOOTNOTES
To read the full text of this article, go to http://www.fasebj.org/cgi/doi/10.1096/fj.04-2469fje; doi: 10.1096/fj.04-2469fje
This article has been cited by other articles:
![]() |
J. Q. van der Merwe, M. D. Hollenberg, and W. K. MacNaughton EGF receptor transactivation and MAP kinase mediate proteinase-activated receptor-2-induced chloride secretion in intestinal epithelial cells Am J Physiol Gastrointest Liver Physiol, February 1, 2008; 294(2): G441 - G451. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ostrowska, E. Sokolova, and G. Reiser PAR-2 activation and LPS synergistically enhance inflammatory signaling in airway epithelial cells by raising PAR expression level and interleukin-8 release Am J Physiol Lung Cell Mol Physiol, November 1, 2007; 293(5): L1208 - L1218. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Kirkland, G. S. Cottrell, N. W. Bunnett, and C. U. Corvera Agonists of protease-activated receptors 1 and 2 stimulate electrolyte secretion from mouse gallbladder Am J Physiol Gastrointest Liver Physiol, July 1, 2007; 293(1): G335 - G346. [Abstract] [Full Text] [PDF] |
||||
![]() |
C A Dinarello and S-H Kim IL-32, a novel cytokine with a possible role in disease Ann Rheum Dis, November 1, 2006; 65(suppl_3): iii61 - iii64. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. T. Abey, D. P. Fairlie, J. D. Moffatt, R. W. Balzary, and T. M. Cocks Protease-Activated Receptor-2 Peptides Activate Neurokinin-1 Receptors in the Mouse Isolated Trachea J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 598 - 605. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Palmer, S. Y. Lee, P. J. Maniak, D. Carlson, S. C. Fahrenkrug, and S. M. O'Grady Protease-activated receptor regulation of Cl- secretion in Calu-3 cells requires prostaglandin release and CFTR activation Am J Physiol Cell Physiol, April 1, 2006; 290(4): C1189 - C1198. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Novick, M. Rubinstein, T. Azam, A. Rabinkov, C. A. Dinarello, and S.-H. Kim Proteinase 3 is an IL-32 binding protein PNAS, February 28, 2006; 103(9): 3316 - 3321. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Matalon and S. I. Rennard Thrombin Increases Lung Water by Decreasing Na,K-ATPase Activity Am. J. Respir. Cell Mol. Biol., October 1, 2005; 33(4): 317 - 318. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |